Indoco Remedies Shares Surge 18% After UK Regulator Clears Goa Plant

Indoco Remedies shares surged 18% after the UK medicines regulator approved the company's Goa facility, signaling a boost in investor confidence. The clearance confirms that the plant meets stringent UK standards for pharmaceutical manufacturing. This approval is a key milestone for the company’s plans to expand its presence in international markets. Investors reacted positively, driving the stock price higher on the day of the announcement.